cro.directory
← Compare landing

Scimega Research vs SciQuus Oncology

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryScimega ResearchSciQuus Oncology
SummaryCanadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors.Full-service CRO specializing in oncology clinical trials, from preclinical IND-enabling studies through Phase I–III trial management, with expertise in First-in-Human studies for new cancer therapies.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Regulatory Affairs
  • In Vivo PK / PD Studies
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • Oncology Specialty Services
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Oncology
  • Oncology
Phases
  • Phase I
  • Phase II
  • Phase III
  • Preclinical (IND-Enabling)
  • Phase I
  • Phase II
  • Phase III
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
Locations
  • Laval, Laval, Québec, Canada
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Scimega Research alternatives · SciQuus Oncology alternatives

Markdown mirror: /compare/scimega/sciquus.md